|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||4.05|
|PE Ratio (TTM)||85.70|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aphria (APHQF) has had one of the weakest months compared to other cannabis companies (HMMJ) such as Canopy Growth (WEED), Supreme Cannabis (SPRWF), and HEXO (HEXO). In this month alone, the stock has declined by nearly 21.4%. Let’s look at what analysts think.
On November 13, Cronos Group (CRON) reported its quarterly results. It posted sales of 3.7 million Canadian dollars, which beat analysts’ consensus estimate of 3.6 million Canadian dollars, and the margins also remained healthy. However, the company’s bottom line struggled. Read more at Key Updates on Cronos Group’s Third-Quarter Earnings. Let’s look at what analysts recommend for the stock.
While the overall markets were filled with negative sentiments, the earnings season for cannabis stocks dampened the excitement in the sector. Most of the cannabis companies missed consensus estimates. In the above chart, you can see some of the big cannabis names (HMMJ) that saw an impressive run-up in October 2018 as marijuana became legal in Canada.
On November 14, Canopy Growth (WEED) (CGC) reported its second-quarter earnings, which largely disappointed the market. As a result, the stock took a beating with an 11% decline to $34.3. The company reported revenues of 23.3 million Canadian dollars, which missed analysts’ estimate of 61.7 million Canadian dollars.
One of the most anticipated aspects of Aurora Cannabis’s (ACB) (ACBFF) earnings results was an update on the recreational cannabis (HMMJ) market demand. In its press release, Aurora Cannabis stated that the company had a “strong performance” in the recreational cannabis segment during the quarter, which ended in September 2018. During the first quarter, the company stated that its brands accounted for nearly 30% of the total cannabis supplied through the OCS (Ontario Cannabis Store) with San Rafael being Aurora’s top brand sold in Ontario.
Aurora Cannabis (ACB) is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter of 2017. Cronos (CRON) is expected to report a loss per share of 0.02 Canadian dollars, which is flat compared to the corresponding quarter a year ago. Tilray (TLRY) is expected to report a loss per share of 0.13 Canadian dollars for the quarter.
As we discussed earlier in this series, cannabis companies (MJ) are expected to report impressive sales growth and healthy margins. However, it’s important to see how these figures could impact cash flows and earnings.
On November 8, Canopy Growth (CGC) (WEED) announced a multiyear partnership with an established logistics and cash management provider—The Brink’s Company (BCO). The Brink’s Company will be used in Canada and global markets where Canopy Growth has operations. Three markets—Brazil, France, and Mexico—show that most of the transactions take place in cash.
On November 7, US Attorney General Jeff Sessions resigned from his position. The Justice Department’s chief of staff, Matt Whitaker, will serve as the acting attorney general. This development could bring some optimism to the cannabis sector in the US, as Jeff Sessions was one of the harshest critics of marijuana.
Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a Quick, ...
LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control. The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits. "We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License.
HENDERSON, NV / ACCESSWIRE / November 1, 2018 / A stem cell play we like a lot is BioRestorative Therapies, Inc.,(BRTX) a life sciences company focused on stem cell-based therapies. Defined Health is a business development and strategy consulting firm that has worked with many of the leading companies in the pharmaceutical, biotech and healthcare industries for over 25 years. BRTX plans to use the results of the review to further refine its planned activities around BRTX-100, including potential licensing, co-development and commercialization activities.
Leading up to the October 17th "legalization date" in Canada, investors saw a surge in cannabis stock interest. Canadian producers and retailers have been unable to keep up with the demand among consumers for cannabis products. With this in mind, we look at 3 marijuana stocks to watch as legalization continues to reach across North America.
HENDERSON, NV / ACCESSWIRE / October 30, 2018 / After a rough week last week for many investors we searched for stocks set up to run this week and help them make up some losses. One company we have discovered ...
LEAMINGTON, ON, Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.
NEW YORK, NY / ACCESSWIRE / October 29, 2018 / U.S. equities rolled back on Friday as disappointing corporate earnings added to the bearish sentiment in the market. The Dow Jones Industrial Average shed ...
HENDERSON, NV / ACCESSWIRE / October 26, 2018 / After pouring over several companies, we've found a few that look set for a major bounce in conjunction with the market. One company we like a lot that is prime for a rebound is BioRestorative Therapies, Inc. (BRTX) a life sciences company focused on stem cell-based therapies. BRTX looks like it has found that support and is on the brink of its next run.
LEAMINGTON, ON, Oct. 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today officially introduced Dr. Jonathan Simone, PhD as the Company's Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company's science, technical and medical division teams and outside medical, academic and clinical centers.
CORAL GABLES, FL / ACCESSWIRE / October 25, 2018 / According to a new report by Grand View Research, Inc., the global legal marijuana market is expected to reach $146.4 billion by end of 2025. This week the market along with several cannabis stocks are looking to turn a corner and head back toward previous highs. Integrated Cannabis Company (ICNAF) (ICAN.CN) reported today that the marijuana company has agreed to license Cannabidiol-formulated gummies.
In this part of the series, we’ll discuss the forward EV-to-EBITDA median multiple of nine cannabis stocks as of October 23.
Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB), Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc. (NASDAQ: CSIQ), Aphria Inc. (TSX: APH.TO), (OTC: APHQF), and Emerald Health Therapeutics, Inc.
HENDERSON, NV / ACCESSWIRE / October 24, 2018 / The cannabis industry took a bit of a hit yesterday, making for several bounce opportunities we've highlighted below. A fascinating biotech firm we discovered ...
HENDERSON, NV / ACCESSWIRE / October 23, 2018 / Last week, one of our favorite CBD companies released some fantastic news. Chineseinvestors.com Inc. (CIIX) announced their Financial Highlights for their ...